Hims & Hers Health Inc. Class A Common Stock (HIMS)

FairStock Score: 27/100 — RISKY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I am wary when a fast-growing consumer health platform loses money after briefly earning it. Hims & Hers grew revenue from $872.0 million in FY2023 to $1.5 billion in FY2024 and $2.3 billion in FY2025, and fiscal Q2 2026 revenue was $753.2 million, up from $544.8 million in fiscal Q2 2025. That top-line momentum is real. But the bottom line has reversed: fiscal Q1 2026 lost $92.1 million and fiscal Q2 2026 lost $86.3 million, after fiscal Q2 2025 earned $42.5 million. FY2025 net income was $128.4 million, so profitability is possible, but the latest two quarters are a red flag. At the close on 2026-10-13, the price was $29.71. On FairStock's calculations, the trailing P/E is negative, P/B is 21.37, ROE is -32.03%, and FCF yield is only 0.9%. The Piotroski F-Score is 3/9 and Altman Z-Score is 1.22, which suggests a fragile financial position. Debt-to-equity of 4.77 and a beta of 2.41 add risk. FairStock scores it 27/100 and classifies it as a turnaround. A durable moat is not evident to me; the business depends on brand, customer acquisition, and regulatory access in a competitive space. Graham would ask for a margin of safety, and Buffett would want consistent earning power. Instead, we have strong revenue growth, positive TTM free cash flow of $61.6 million, but renewed losses and a rich price relative to current profits and cash flow. This is a speculative turnaround, not a conservative value compounder.

In plain English: Hims & Hers sells health and wellness products and online access to licensed healthcare professionals. Sales are growing quickly, but the company lost money in the latest two quarters after being profitable earlier. At $29.71 on 2026-10-13, the price looks expensive compared with the money the company currently earns and generates.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer